ITEOS THERAPEUTICS INC's ticker is ITOS and the CUSIP is 46565G104. A total of 82 filers reported holding ITEOS THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $48,368,986 | -17.3% | 4,417,259 | 0.0% | 0.95% | -13.8% |
Q2 2023 | $58,484,509 | -2.7% | 4,417,259 | 0.0% | 1.10% | -18.9% |
Q1 2023 | $60,118,895 | -30.3% | 4,417,259 | 0.0% | 1.36% | -22.2% |
Q4 2022 | $86,269,068 | +2.5% | 4,417,259 | 0.0% | 1.75% | -2.5% |
Q3 2022 | $84,149,000 | -7.5% | 4,417,259 | 0.0% | 1.80% | -26.0% |
Q2 2022 | $90,996,000 | -36.0% | 4,417,259 | 0.0% | 2.43% | -21.8% |
Q1 2022 | $142,147,000 | -30.9% | 4,417,259 | 0.0% | 3.10% | -14.5% |
Q4 2021 | $205,668,000 | +72.4% | 4,417,259 | 0.0% | 3.63% | +119.4% |
Q3 2021 | $119,266,000 | +5.3% | 4,417,259 | 0.0% | 1.65% | -9.1% |
Q2 2021 | $113,303,000 | -25.0% | 4,417,259 | +0.0% | 1.82% | -20.1% |
Q1 2021 | $150,982,000 | +1.1% | 4,417,258 | 0.0% | 2.28% | +9.1% |
Q4 2020 | $149,392,000 | +37.1% | 4,417,258 | 0.0% | 2.09% | +4.8% |
Q3 2020 | $108,974,000 | – | 4,417,258 | – | 1.99% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 2,738,785 | $37,274,864 | 15.53% |
MPM BioImpact LLC | 1,745,943 | $23,762,284 | 6.17% |
Saturn V Capital Management LP | 480,653 | $6,541,687 | 4.89% |
Boxer Capital, LLC | 2,154,058 | $29,317 | 1.44% |
RA Capital Management | 4,417,259 | $60,118,895 | 1.36% |
Octagon Capital Advisors LP | 596,000 | $8,111,560 | 1.17% |
BVF INC/IL | 1,810,835 | $24,645,464 | 0.90% |
AlphaCentric Advisors LLC | 63,000 | $857,430 | 0.59% |
Integral Health Asset Management, LLC | 180,000 | $2,449,800 | 0.49% |
683 Capital Management, LLC | 480,000 | $6,532,800 | 0.49% |